Literature DB >> 3752106

Comparison of three algorithms used to evaluate adverse drug reactions.

D J Michel, L C Knodel.   

Abstract

The consistency of three algorithms in evaluating adverse drug reactions (ADRs) was studied. As part of a hospital's ADR protocol, doctor of pharmacy students were required to collect and summarize all ADR data. Algorithms by Kramer, Naranjo, and Jones were used to evaluate all ADRs between January and May 1984. Kramer's algorithm was used for every reported ADR; Naranjo's and Jones' algorithms were used to check consistency in scoring among ADRs already scored with the Kramer algorithm. The two numerical scales (Kramer and Naranjo) were compared using linear regression. The results of all three algorithms were translated into categories of suspicion (A = definite or probable; B = probable; C = possible; and D = unlikely, doubtful, or remote) and evaluated for consistency with a weighted kappa (kw) statistical test. A total of 28 ADRs were evaluated, and the correlation (r = 0.87) between the total numerical scores of the Kramer and Naranjo algorithms was significant. Comparison of the Kramer and Naranjo algorithms showed 67% agreement with a kw value of 0.43 (-1 = perfect disagreement and +1 = perfect agreement). Similarly, there was 67% agreement (kw = 0.48) between Kramer's algorithm and Jones' algorithm. Agreement between Naranjo's and Jones's algorithms was 64%, but the kw value was only 0.28. The simpler and less time-consuming Naranjo algorithm compared favorably with the Kramer algorithm in scoring ADRs; more data are needed to support the use of the Jones algorithm.

Entities:  

Mesh:

Year:  1986        PMID: 3752106

Source DB:  PubMed          Journal:  Am J Hosp Pharm        ISSN: 0002-9289


  18 in total

1.  Comparison of three pharmacovigilance algorithms in the ICU setting: a retrospective and prospective evaluation of ADRs.

Authors:  Sandra L Kane-Gill; Elizabeth A Forsberg; Margaret M Verrico; Steven M Handler
Journal:  Drug Saf       Date:  2012-08-01       Impact factor: 5.606

Review 2.  Clinical trials and clinical practice in the elderly. A focus on hypertension.

Authors:  M E Kitler
Journal:  Drugs Aging       Date:  1992 Mar-Apr       Impact factor: 3.923

3.  Computerized surveillance of adverse drug events in hospital patients. 1991.

Authors:  D C Classen; S L Pestotnik; R S Evans; J P Burke
Journal:  Qual Saf Health Care       Date:  2005-06

4.  Can decisional algorithms replace global introspection in the individual causality assessment of spontaneously reported ADRs?

Authors:  Ana F Macedo; Francisco B Marques; Carlos F Ribeiro
Journal:  Drug Saf       Date:  2006       Impact factor: 5.606

Review 5.  Methods for causality assessment of adverse drug reactions: a systematic review.

Authors:  Taofikat B Agbabiaka; Jelena Savović; Edzard Ernst
Journal:  Drug Saf       Date:  2008       Impact factor: 5.606

6.  Health outcomes associated with potentially inappropriate medication use in older adults.

Authors:  Donna M Fick; Lorraine C Mion; Mark H Beers; Jennifer L Waller
Journal:  Res Nurs Health       Date:  2008-02       Impact factor: 2.228

7.  Prevalence of unplanned hospitalizations caused by adverse drug reactions in older veterans.

Authors:  Zachary A Marcum; Megan E Amuan; Joseph T Hanlon; Sherrie L Aspinall; Steven M Handler; Christine M Ruby; Mary Jo V Pugh
Journal:  J Am Geriatr Soc       Date:  2011-12-08       Impact factor: 5.562

8.  Desire for information about drugs: relationships with patients' characteristics and adverse effects.

Authors:  R Laaksonen; C Duggan; I Bates
Journal:  Pharm World Sci       Date:  2002-10

Review 9.  Clinical features and management of severe dermatological reactions to drugs.

Authors:  M C Raviglione; A Pablos-Mendez; R Battan
Journal:  Drug Saf       Date:  1990 Jan-Feb       Impact factor: 5.606

Review 10.  Safety of green tea extracts : a systematic review by the US Pharmacopeia.

Authors:  Dandapantula N Sarma; Marilyn L Barrett; Mary L Chavez; Paula Gardiner; Richard Ko; Gail B Mahady; Robin J Marles; Linda S Pellicore; Gabriel I Giancaspro; Tieraona Low Dog
Journal:  Drug Saf       Date:  2008       Impact factor: 5.606

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.